|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-9-24
|
|
pubmed:abstractText |
Overexpression of epidermal growth factor receptor (EGFR) has been correlated with tumor resistance to radiation. Blockade of EGFR with C225 anti-EGFR antibody was previously shown to synergistically enhance radiation-induced tumor growth delay. The purpose of this study was to assess whether C225 can increase tumor cure by radiation.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
474-7
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:11567823-Animals,
pubmed-meshheading:11567823-Antibodies, Monoclonal,
pubmed-meshheading:11567823-Antineoplastic Agents,
pubmed-meshheading:11567823-Dose-Response Relationship, Radiation,
pubmed-meshheading:11567823-Humans,
pubmed-meshheading:11567823-Male,
pubmed-meshheading:11567823-Mice,
pubmed-meshheading:11567823-Mice, Nude,
pubmed-meshheading:11567823-Neoplasm Proteins,
pubmed-meshheading:11567823-Neoplasm Recurrence, Local,
pubmed-meshheading:11567823-Neoplasms,
pubmed-meshheading:11567823-Radiobiology,
pubmed-meshheading:11567823-Radiotherapy Dosage,
pubmed-meshheading:11567823-Receptor, Epidermal Growth Factor,
pubmed-meshheading:11567823-Transplantation, Heterologous
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
|
|
pubmed:affiliation |
Department of Experimental Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
